atorvastatin has been researched along with Peripheral Arterial Disease in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (87.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bellomo, T; Boada, AE; Dua, A; Goudot, G; Hall, RP; Jessula, S; Kukreja, N; Lee, I; Majumdar, M; Parmar, G; Suarez Ferreira, SP | 1 |
| Mehta, A; Sperling, LS; Wells, BJ | 1 |
| Li, K; Li, T; Zhai, S; Zhang, K; Zhang, Z | 1 |
| Amsterdam, EA; Armstrong, EJ; Choy, HK; Foley, TR; Kokkinidis, DG; Laird, JR; Pham, T; Rutledge, JC; Singh, GD; Waldo, SW | 1 |
| Ballantyne, CM; Baum, SJ; Davidson, MH; Koren, A; Langslet, G; Mandel, J; McCullough, PA; Sanganalmath, SK; Shah, PK | 1 |
| Cao, W; Cao, Z; Chen, X; Cheng, J; Gao, W; Guo, S; Jiang, Y; Li, B; Li, M; Li, Q; Li, X; Li, Z; Peng, C; Shen, J; Sun, J; Sun, X; Tian, F; Tian, Y; Tian, Z; Wang, H; Wang, P; Wang, T; Wang, W; Wang, Y; Yang, J; Yang, Y; Yao, J; Zhang, Z; Zhao, X; Zhou, Q | 1 |
| Danielak, D; Gorzycka, P; Główka, F; Karaźniewicz-Łada, M; Kruszyna, Ł | 1 |
| Antova, E; Bosevska, G; Bosevski, M; Krstevski, G; Mitevska, I | 1 |
| Boekholdt, SM; Fayyad, R; Hovingh, GK; Laskey, R; Pedersen, TR; Stoekenbroek, RM; Tikkanen, MJ | 1 |
| Bonaca, MP; Creager, MA | 1 |
| Bando, YK; Monji, A; Morimoto, Y; Murohara, T; Shigeta, T | 1 |
| Antovic, A; Antovic, J; Bröijersen, A; Egberg, N; He, S; Jörneskog, G; Mobarrez, F; Wallén, H; Wiklund, B | 1 |
| Lip, GY; Montoro-García, S; Shantsila, E | 1 |
| Koppensteiner, R; Spring, S; van der Loo, B | 1 |
| Antovic, J; Bröijersen, A; Egberg, N; Jörneskog, G; Mobarrez, F; Wallén, H | 1 |
| Buszman, PE; Buszman, PP; Kiesz, RS; Konkolewska, MD; Martin, JL; Radvany, MG; Szymanski, R; Wiernek, BK; Wiernek, SL | 1 |
1 review(s) available for atorvastatin and Peripheral Arterial Disease
| Article | Year |
|---|---|
Pharmacological treatment and current management of peripheral artery disease.
Topics: Atorvastatin; Exercise; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Simvastatin; Smoking Cessation; Treatment Outcome | 2015 |
4 trial(s) available for atorvastatin and Peripheral Arterial Disease
| Article | Year |
|---|---|
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease.
Topics: Aged; Atorvastatin; Cholesterol, LDL; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Netherlands; Peripheral Arterial Disease; Prospective Studies; Pyrroles; Scandinavian and Nordic Countries; Simvastatin | 2015 |
Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease.
Topics: Aged; Atorvastatin; Blood Platelets; Cell-Derived Microparticles; Cross-Over Studies; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Integrin beta3; Male; Middle Aged; P-Selectin; Peripheral Arterial Disease; Pyrroles; Thrombin; Thromboplastin | 2011 |
High-dose atorvastatin treatment in patients with peripheral arterial disease: effects on platelet aggregation, blood rheology and plasma homocysteine.
Topics: Aged; Atorvastatin; Female; Hemorheology; Heptanoic Acids; Homocysteine; Humans; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation; Prospective Studies; Pyrroles | 2011 |
Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study.
Topics: Aged; Antigens, CD; Atorvastatin; Biomarkers; Cadherins; Cell-Derived Microparticles; Cross-Over Studies; Double-Blind Method; Endothelial Cells; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Peripheral Arterial Disease; Placebos; Pyrroles; Sweden; Thromboplastin; Time Factors; Treatment Outcome | 2012 |
11 other study(ies) available for atorvastatin and Peripheral Arterial Disease
| Article | Year |
|---|---|
Atorvastatin Effect on Clopidogrel Efficacy in Patients with Peripheral Artery Disease.
Topics: Anticoagulants; Aspirin; Atorvastatin; Clopidogrel; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine; Treatment Outcome; Venous Thromboembolism | 2023 |
Postexercise Ankle-Brachial Index Testing.
Topics: Ankle Brachial Index; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Atorvastatin; Exercise; Exercise Test; Exercise Therapy; Female; Humans; Intermittent Claudication; Lisinopril; Middle Aged; Peripheral Arterial Disease | 2020 |
Effect of Atorvastatin on lower extremity function of patients with hypertension and peripheral arterial disease.
Topics: Atorvastatin; Blood Pressure; Female; Humans; Hypertension; Lower Extremity; Male; Peripheral Arterial Disease; Walking | 2017 |
High-Intensity Statin Therapy Is Associated With Improved Survival in Patients With Peripheral Artery Disease.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Angiography; Atorvastatin; Biomarkers; Critical Illness; Disease Progression; Disease-Free Survival; Drug Prescriptions; Dyslipidemias; Endovascular Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Lipids; Male; Middle Aged; Peripheral Arterial Disease; Practice Patterns, Physicians'; Registries; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Time Factors; Treatment Outcome | 2017 |
Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials).
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Cholesterol, LDL; Clinical Trials, Phase III as Topic; Coronary Disease; Drug Therapy, Combination; Female; Heterozygote; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Maximum Tolerated Dose; Middle Aged; PCSK9 Inhibitors; Peripheral Arterial Disease; Risk; Rosuvastatin Calcium; Simvastatin; Stroke; Treatment Outcome | 2018 |
Rapid inhibition of atherosclerotic plaque progression by sonodynamic therapy.
Topics: Aminolevulinic Acid; Animals; Aortic Diseases; Apoptosis; Atorvastatin; Carotid Artery Diseases; Cells, Cultured; Combined Modality Therapy; Disease Models, Animal; Disease Progression; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Peripheral Arterial Disease; Pilot Projects; Plaque, Atherosclerotic; Rabbits; Time Factors; Treatment Outcome; Ultrasonic Therapy | 2019 |
Development of an LC-MS/MS method for simultaneous determination of ticagrelor and its active metabolite during concomitant treatment with atorvastatin.
Topics: Atorvastatin; Chromatography, Liquid; Humans; Limit of Detection; Linear Models; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Reproducibility of Results; Tandem Mass Spectrometry; Ticagrelor | 2019 |
Hyperfibrinogenemia in Peripheral Arterial Disease: Coexistent and Independent Risk Factor (A Report of Two Cases and Review of Literature).
Topics: Amputation, Surgical; Anticholesteremic Agents; Atorvastatin; Diabetes Mellitus, Type 2; Fenofibrate; Fibrinogen; Humans; Hypolipidemic Agents; Intermittent Claudication; Ischemia; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Predictive Value of Tests; Risk Factors; Treatment Outcome | 2018 |
Atorvastatin prevents ischemic limb loss in type 2 diabetes: role of p53.
Topics: Animals; Atorvastatin; Blotting, Western; Cells, Cultured; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Extremities; Heart; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Ischemia; Male; Mice; Myoblasts; Peripheral Arterial Disease; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Pyrroles; Tumor Suppressor Protein p53; Ubiquitin; Wound Healing | 2011 |
Atorvastatin and its collateral effects on microparticles.
Topics: Atorvastatin; Blood Platelets; Cell-Derived Microparticles; Female; Heptanoic Acids; Humans; Male; Peripheral Arterial Disease; Pyrroles | 2011 |
Long-term results of plaque excision combined with aggressive pharmacotherapy in high-risk patients with advanced peripheral artery disease (SAVE a LEG registry).
Topics: Adult; Aged; Aged, 80 and over; Amputation, Surgical; Aspirin; Atherectomy; Atorvastatin; Cardiovascular Agents; Clopidogrel; Combined Modality Therapy; Critical Illness; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Intermittent Claudication; Ischemia; Kaplan-Meier Estimate; Limb Salvage; Male; Middle Aged; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrroles; Recurrence; Registries; Retrospective Studies; Risk Factors; Severity of Illness Index; Ticlopidine; Time Factors; Treatment Outcome | 2013 |